These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
569 related articles for article (PubMed ID: 9132006)
1. Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes. Derry WB; Wilson L; Khan IA; Luduena RF; Jordan MA Biochemistry; 1997 Mar; 36(12):3554-62. PubMed ID: 9132006 [TBL] [Abstract][Full Text] [Related]
2. Low potency of taxol at microtubule minus ends: implications for its antimitotic and therapeutic mechanism. Derry WB; Wilson L; Jordan MA Cancer Res; 1998 Mar; 58(6):1177-84. PubMed ID: 9515803 [TBL] [Abstract][Full Text] [Related]
3. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells. Kowalski RJ; Giannakakou P; Gunasekera SP; Longley RE; Day BW; Hamel E Mol Pharmacol; 1997 Oct; 52(4):613-22. PubMed ID: 9380024 [TBL] [Abstract][Full Text] [Related]
4. Characterization of nuclear betaII-tubulin in tumor cells: a possible novel target for taxol. Xu K; Ludueña RF Cell Motil Cytoskeleton; 2002 Sep; 53(1):39-52. PubMed ID: 12211114 [TBL] [Abstract][Full Text] [Related]
5. Substoichiometric binding of taxol suppresses microtubule dynamics. Derry WB; Wilson L; Jordan MA Biochemistry; 1995 Feb; 34(7):2203-11. PubMed ID: 7857932 [TBL] [Abstract][Full Text] [Related]
7. Dicoumarol: a unique microtubule stabilizing natural product that is synergistic with Taxol. Madari H; Panda D; Wilson L; Jacobs RS Cancer Res; 2003 Mar; 63(6):1214-20. PubMed ID: 12649179 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of natural product microtubule stabilizers on microtubule assembly: single agent and combination studies with taxol, epothilone B, and discodermolide. Gertsch J; Meier S; Müller M; Altmann KH Chembiochem; 2009 Jan; 10(1):166-75. PubMed ID: 19058273 [TBL] [Abstract][Full Text] [Related]
9. Elongation factor-1alpha stabilizes microtubules in a calcium/calmodulin-dependent manner. Moore RC; Durso NA; Cyr RJ Cell Motil Cytoskeleton; 1998; 41(2):168-80. PubMed ID: 9786091 [TBL] [Abstract][Full Text] [Related]
10. Identification of a novel taxol-sensitive kinase activity associated with the cytoskeleton. Wang Y; Duncan R; Ann DK; Hamm-Alvarez SF Biochem Biophys Res Commun; 2000 Nov; 277(3):525-30. PubMed ID: 11061987 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of the unusually potent microtubule inhibitor cryptophycin 1. Panda D; Himes RH; Moore RE; Wilson L; Jordan MA Biochemistry; 1997 Oct; 36(42):12948-53. PubMed ID: 9335554 [TBL] [Abstract][Full Text] [Related]
12. Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells. Ranganathan S; McCauley RA; Dexter DW; Hudes GR Br J Cancer; 2001 Sep; 85(5):735-40. PubMed ID: 11531260 [TBL] [Abstract][Full Text] [Related]
13. Removal of beta III isotype enhances taxol induced microtubule assembly. Lu Q; Luduena RF Cell Struct Funct; 1993 Jun; 18(3):173-82. PubMed ID: 7902216 [TBL] [Abstract][Full Text] [Related]
14. Suppression of microtubule dynamics by binding of cemadotin to tubulin: possible mechanism for its antitumor action. Jordan MA; Walker D; de Arruda M; Barlozzari T; Panda D Biochemistry; 1998 Dec; 37(50):17571-8. PubMed ID: 9860873 [TBL] [Abstract][Full Text] [Related]
15. Fluorescent taxoids as probes of the microtubule cytoskeleton. Evangelio JA; Abal M; Barasoain I; Souto AA; Lillo MP; Acuña AU; Amat-Guerri F; Andreu JM Cell Motil Cytoskeleton; 1998; 39(1):73-90. PubMed ID: 9453715 [TBL] [Abstract][Full Text] [Related]
16. Increased levels of tyrosinated alpha-, beta(III)-, and beta(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells. Banerjee A Biochem Biophys Res Commun; 2002 Apr; 293(1):598-601. PubMed ID: 12054644 [TBL] [Abstract][Full Text] [Related]
17. Suppression of centromere dynamics by Taxol in living osteosarcoma cells. Kelling J; Sullivan K; Wilson L; Jordan MA Cancer Res; 2003 Jun; 63(11):2794-801. PubMed ID: 12782584 [TBL] [Abstract][Full Text] [Related]
18. Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-Anticancer Drug Screen: correlation with sensitivity to microtubule active agents. Nicoletti MI; Valoti G; Giannakakou P; Zhan Z; Kim JH; Lucchini V; Landoni F; Mayo JG; Giavazzi R; Fojo T Clin Cancer Res; 2001 Sep; 7(9):2912-22. PubMed ID: 11555610 [TBL] [Abstract][Full Text] [Related]
19. Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol. ter Haar E; Kowalski RJ; Hamel E; Lin CM; Longley RE; Gunasekera SP; Rosenkranz HS; Day BW Biochemistry; 1996 Jan; 35(1):243-50. PubMed ID: 8555181 [TBL] [Abstract][Full Text] [Related]
20. Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: reversibility, ligand stoichiometry, and competition. Díaz JF; Andreu JM Biochemistry; 1993 Mar; 32(11):2747-55. PubMed ID: 8096151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]